Oxygen Transport to Tissue XXXIV

Professor Britton Chance was one of the most outstanding scientists in the world. He was born on July 24, 1913 in Wilkes-Barre, PA, USA and passed away on November 16th, 2010 in Philadelphia at the age of 97. He has left with us a tremendous legacy that many other extraordinary human beings cannot match. As a scientist and an engineer, he has invented and developed numerous physical instruments and employed them to answer some of the most pressing research questions in biology and medicine, ranging from enzyme kinetics through bioenergetics and electron transport in mitochondria, reactive oxygen species, quantum tunneling in biology, in vivo NMR, to biophotonics for brain functional studies and the detection, diagnosis, and treatment of diseases. He had a high impact on every major research field in which he worked and was regarded as a founding father for mitochondrial bioenergetics, redox sciences, in vivo NMR, and biophotonics. With his keen capacities in electronics, he worked in the MIT Radiation Lab on precision bombing and radar systems that were used in World War II and contributed to the development of the world’s first general purpose computer, ENIAC, at the University of Pennsylvania. As an athlete, he won an Olympic gold medal (5.5 m sailing) in Helsinki in 1952 and several World Championships in the late 1950s–1960s. He was a member of the National Academy of Sciences in the USA and an academician in five other countries. He won the National Medal of Sciences in 1974. As an educator, he tirelessly trained thousands of students and researchers and many of them have become established leaders in various fields of scientific research. He had been an ISOTT member since the founding of the Society and was President of ISOTT in 1976. In his 90s, he traveled to China, Singapore, and Taiwan for various research and educational activities and helped local scientists to develop cutting-edge research projects and institutions. In 2008 and 2009 he received the two highest honors for foreign scientists from the Chinese government.

[1]  D. Siemann,et al.  Utility of 19F MRS detection of the hypoxic cell marker EF5 to assess cellular hypoxia in solid tumors. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  Suresh Poosala,et al.  Red cell interactions with amyloid-β1–40 fibrils in a murine model , 2005, Neurobiology of Disease.

[3]  D. Royall,et al.  Alzheimer disease as a vascular disorder: nosological evidence. , 2002, Stroke.

[4]  H. Kozłowski,et al.  Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). , 2006, Chemical reviews.

[5]  H. Ha,et al.  High Glucose Increases Inducible NO Production in Cultured Rat Mesangial Cells , 2001, Nephron.

[6]  P. Manoharan,et al.  Redox reactions of hemoglobin. , 2004, Antioxidants & redox signaling.

[7]  Simon R. Arridge,et al.  Elsevier Editorial System(tm) for NeuroImage Manuscript Draft Manuscript Number: Title: THREE DIMENSIONAL OPTICAL IMAGING OF BLOOD VOLUME AND OXYGENATION IN THE NEONATAL BRAIN , 2005 .

[8]  T. Miyata,et al.  Inhibition of Advanced Glycation End Products , 2008, Annals of the New York Academy of Sciences.

[9]  Kevin J Black,et al.  Blood flow imaging of the brain: 50 years experience. , 2005, The Journal of neuropsychiatry and clinical neurosciences.

[10]  H. Aynedjian,et al.  Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. , 1993, Kidney international.

[11]  Jarod C Finlay,et al.  Hemoglobin oxygen saturations in phantoms and in vivo from measurements of steady-state diffuse reflectance at a single, short source-detector separation. , 2004, Medical physics.

[12]  A. Hartner,et al.  J Am Soc Nephrol 11: 71–79, 2000 Nitric Oxide Synthase Isoforms and Glomerular Hyperfiltration in Early Diabetic Nephropathy , 2022 .

[13]  J. G. Mohanty,et al.  Role of the membrane in the formation of heme degradation products in red blood cells. , 2010, Life sciences.

[14]  J. Magat,et al.  In vivo mapping of tumor oxygen consumption using 19F MRI relaxometry , 2011, NMR in biomedicine.

[15]  J. Rifkind,et al.  Formation of fluorescent heme degradation products during the oxidation of hemoglobin by hydrogen peroxide. , 1998, Biochemical and biophysical research communications.

[16]  D. Beyersdorff,et al.  [Pharmacokinetic MRI of the prostate: parameters for differentiating low-grade and high-grade prostate cancer]. , 2009, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[17]  P. Jakob,et al.  Monitoring of Tumor Oxygenation Changes in Head-and-Neck Carcinoma Patients Breathing a Hyperoxic Hypercapnic Gas Mixture with a Noninvasive MRI Technique , 2009, Strahlentherapie und Onkologie.

[18]  D. Bainbridge,et al.  Monitoring Brain Oxygen Saturation During Coronary Bypass Surgery: A Randomized, Prospective Study , 2007, Anesthesia and analgesia.

[19]  D. Holtzman,et al.  Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease , 2008, Nature.

[20]  S. Sensi,et al.  Alzheimer's disease, metal ions and metal homeostatic therapy. , 2009, TIPS - Trends in Pharmacological Sciences.

[21]  S. Shin,et al.  Validation and application of a microfluidic ektacytometer (RheoScan-D) in measuring erythrocyte deformability. , 2007, Clinical hemorheology and microcirculation.

[22]  Xiaoying Wang,et al.  Blood oxygen level-dependent MRI for the monitoring of neoadjuvant chemotherapy in breast carcinoma: initial experience. , 2011, Magnetic resonance imaging.

[23]  H. Vlassara,et al.  Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis. , 2009, Endocrinology.

[24]  H. Halpern,et al.  Electron paramagnetic resonance oxygen imaging of a rabbit tumor using localized spin probe delivery. , 2010, Medical physics.

[25]  D. Schwartz,et al.  An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats. , 2001, The Journal of laboratory and clinical medicine.

[26]  Martin A Lodge,et al.  Reproducibility of Tumor Blood Flow Quantification with 15O-Water PET , 2008, Journal of Nuclear Medicine.

[27]  J. Stone.  What initiates the formation of senile plaques? The origin of Alzheimer-like dementias in capillary haemorrhages. , 2008, Medical hypotheses.

[28]  Mark E. Williams,et al.  Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy , 2004, American Journal of Nephrology.

[29]  J. Overgaard.  Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck--a systematic review and meta-analysis. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  S. Hughes,et al.  Heating characteristics of a 434 MHz transurethral system for the treatment of BPH and interstitial thermometry. , 1996, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[31]  V. Natarajan,et al.  Vascular endothelial barrier dysfunction mediated by amyloid-beta proteins. , 2009, Journal of Alzheimer's disease : JAD.

[32]  P. Okunieff,et al.  Measurement of human tumor blood flow: a positron technique using an artifact of high energy radiation therapy. , 1992, Advances in experimental medicine and biology.

[33]  H. Vinters,et al.  Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[34]  P. López-Larrubia,et al.  Imaging tumor hypoxia by magnetic resonance methods , 2011, NMR in Biomedicine.